Total planned funding: $117,400,099
Allocations
Countries/Regions
| India | $117,400,099 |
Organizational Types
| Unknown | $72,905,599 |
| NGO | $19,595,145 |
| Own Agency | $14,332,547 |
| University | $3,200,000 |
| Implementing Agency | $3,100,000 |
| Multi-lateral Agency | $1,956,808 |
| Private Contractor | $1,509,000 |
| Host Country Government Agency | $601,000 |
| FBO | $200,000 |
| Other USG Agency | $0 |
Program Areas
| Governance and Systems | $54,669,123 |
| Prevention | $25,061,724 |
| Management and Operations | $11,439,552 |
| Care | $10,742,083 |
| Testing | $5,706,976 |
| Treatment | $5,352,849 |
Budget Codes
| OHSS: Health Systems Strengthening | $32,848,609 |
| HVSI: Strategic Information | $18,267,419 |
| HVMS: Management and Operations | $11,439,552 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,091,100 |
| HBHC: Care: Adult Care and Support | $6,978,734 |
| HVCT: Testing: HIV Testing and Counseling | $5,706,976 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,475,469 |
| HTXS: Treatment: Adult Treatment | $5,245,989 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $4,660,053 |
| HLAB: Laboratory Infrastructure | $3,553,095 |
| HKID: Care: Orphans and Vulnerable Children | $2,864,166 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,361,076 |
| HMBL: Biomedical Prevention: Blood Safety | $1,474,026 |
| HVTB: Care: TB/HIV | $829,183 |
| PDTX: Treatment: Pediatric Treatment | $106,860 |
| PDCS: Care: Pediatric Care and Support | $70,000 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$72,905,599
Countries/Regions
FHI 360:
$14,287,057
Countries/Regions
USG Aggregated Agencies:
$11,758,132
Countries/Regions
University of Washington:
$3,200,000
Countries/Regions